CHIEF FINANCIAL OFFICER
CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc., filing insider transactions between 2026-07-17 and 2026-09-17.
| SEC ↗ |
| 2026-08-17 | ELVN | Sale | 1,388 | $59.35 | $82K | SEC ↗ |
| 2026-08-17 | ELVN | Sale | 4,630 | $58.35 | $270K | SEC ↗ |
| 2026-07-17 | ELVN | Sale | 123 | $53.87 | $7K | SEC ↗ |
| 2026-07-17 | ELVN | Sale | 2,564 | $52.32 | $134K | SEC ↗ |
| 2026-07-17 | ELVN | Sale | 324 | $49.97 | $16K | SEC ↗ |
| 2026-07-17 | ELVN | Sale | 2,638 | $53.38 | $141K | SEC ↗ |
| 2026-07-17 | ELVN | Sale | 369 | $51.48 | $19K | SEC ↗ |